Mon.Dec 25, 2023

article thumbnail

Fish Oil vs. Plant Omega-3s: Best Health Source

Welltopia Pharmacy

Fish Oil vs.

111
111
article thumbnail

Intas Pharma signs licensing pact with mAbxience for etanercept biosimilar

Express Pharma

Intas Pharmaceuticals has signed an exclusive licensing agreement with mAbxience ( a Fresenius Kabi majority-owned group with partial ownership from Insud Pharma) for biosimilar for Etanercept. Etanercept is a dimeric fusion protein with tumor necrosis factor (TNF) blocking action, that was approved for use over 20 years ago, offering patients a valuable therapeutic option for treating various autoimmune diseases.

Insiders

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

article thumbnail

Which pharmaceutical companies have the most SPCs in Finland?

Drug Patent Watch

This chart shows the pharmaceutical companies with the most supplementary protection certificates (SPCs) in Finland. SPCs are used in European Union and select others to encourage pharmaceutical innovation by compensating… The post Which pharmaceutical companies have the most SPCs in Finland? appeared first on DrugPatentWatch - Make Better Decisions.

article thumbnail

Cabometyx by Exelixis for Gastric Cancer: Likelihood of Approval

Pharmaceutical Technology

Cabometyx is under clinical development by Exelixis and currently in Phase II for Gastric Cancer.

52
article thumbnail

Navigating Payroll Compliance: Future-Proofing Payroll in an Evolving Regulatory Landscape

Speaker: Jennifer Hill

Payroll compliance is a cornerstone of business success, yet for small and midsize businesses, it’s becoming increasingly challenging to navigate the ever-evolving landscape of federal, state, and local regulations. Mistakes can lead to costly penalties and operational disruptions, making it essential to adopt advanced solutions that ensure accuracy and efficiency.

article thumbnail

Drug Patent Expirations for the Week of December 24, 2023

Drug Patent Watch

COREG CR (carvedilol phosphate) Woodward Patent: 7,268,156 Expiration: Dec 27, 2023 See More … For more information on how DrugPatentWatch can help with your pharmaceutical business intelligence needs, contact admin@DrugPatentWatch.com… The post Drug Patent Expirations for the Week of December 24, 2023 appeared first on DrugPatentWatch - Make Better Decisions.

59
article thumbnail

Ribociclib succinate by Novartis for Oligodendroglioma: Likelihood of Approval

Pharmaceutical Technology

Ribociclib succinate is under clinical development by Novartis and currently in Phase II for Oligodendroglioma.

52

More Trending

article thumbnail

Opaganib by RedHill Biopharma for Bile Duct Cancer (Cholangiocarcinoma): Likelihood of Approval

Pharmaceutical Technology

Opaganib is under clinical development by RedHill Biopharma and currently in Phase II for Bile Duct Cancer (Cholangiocarcinoma).

52
article thumbnail

Top 3 Podcast Episodes of the Year

Pharmaceutical Commerce

This year’s PC Podcast episodes ranged in topic, from DSCSA compliance to pharmacovigilance.

52
article thumbnail

HCW-9218 by HCW Biologics for Ovarian Cancer: Likelihood of Approval

Pharmaceutical Technology

HCW-9218 is under clinical development by HCW Biologics and currently in Phase I for Ovarian Cancer.

52
article thumbnail

Top 5 Pharmacy Times Alzheimer Disease Articles of 2023

Pharmacy Times

From newsworthy moments to groundbreaking research, these were the most-read Alzheimer disease-related articles on Pharmacy Times in 2023.

32
article thumbnail

From Diagnosis to Delivery: How AI is Revolutionizing the Patient Experience

Speaker: Simran Kaur, Founder & CEO at Tattva Health Inc.

The healthcare landscape is being revolutionized by AI and cutting-edge digital technologies, reshaping how patients receive care and interact with providers. In this webinar led by Simran Kaur, we will explore how AI-driven solutions are enhancing patient communication, improving care quality, and empowering preventive and predictive medicine. You'll also learn how AI is streamlining healthcare processes, helping providers offer more efficient, personalized care and enabling faster, data-driven

article thumbnail

ZB-131 by ZielBio for Gallbladder Cancer: Likelihood of Approval

Pharmaceutical Technology

ZB-131 is under clinical development by ZielBio and currently in Phase II for Gallbladder Cancer.

52
article thumbnail

Top 5 Pharmacy Times Pharmacy Technician Articles of 2023

Pharmacy Times

From newsworthy moments to groundbreaking research, these were the most-read pharmacy technician-related articles on Pharmacy Times in 2023.

article thumbnail

Efineptakin alfa by NeoImmuneTech for Solid Tumor: Likelihood of Approval

Pharmaceutical Technology

Efineptakin alfa is under clinical development by NeoImmuneTech and currently in Phase II for Solid Tumor.

52
article thumbnail

Top 5 Pharmacy Times Biosimilar Articles of 2023

Pharmacy Times

From newsworthy moments to groundbreaking research, these were the most-read biosimilar-related articles on Pharmacy Times in 2023.

article thumbnail

Why Every Small Business Needs an HCM Solution: A Comprehensive Guide

Managing HR tasks like payroll, compliance, and employee data can overwhelm small businesses. That’s where a Human Capital Management (HCM) solution comes in. Our eBook, Why Every Small Business Needs an HCM Solution: A Comprehensive Guide , shows how an HCM system automates tedious processes, ensuring your business stays compliant and efficient. You’ll learn how to simplify payroll, eliminate costly errors, and empower your employees with self-service tools.

article thumbnail

Disitamab vedotin by RemeGen for Cervical Cancer: Likelihood of Approval

Pharmaceutical Technology

Disitamab vedotin is under clinical development by RemeGen and currently in Phase I for Cervical Cancer.

52
article thumbnail

BDTX-4933 by Black Diamond Therapeutics for Solid Tumor: Likelihood of Approval

Pharmaceutical Technology

BDTX-4933 is under clinical development by Black Diamond Therapeutics and currently in Phase I for Solid Tumor.

40
article thumbnail

BDTX-4933 by Black Diamond Therapeutics for Non-Small Cell Lung Cancer: Likelihood of Approval

Pharmaceutical Technology

BDTX-4933 is under clinical development by Black Diamond Therapeutics and currently in Phase I for Non-Small Cell Lung Cancer.

40
article thumbnail

BDTX-4933 by Black Diamond Therapeutics for Thyroid Cancer: Likelihood of Approval

Pharmaceutical Technology

BDTX-4933 is under clinical development by Black Diamond Therapeutics and currently in Phase I for Thyroid Cancer.

40
article thumbnail

Best Practices to Streamline Compensation Management: A Foundation for Growth

Speaker: Joe Sharpe and James Carlson

Payroll optimization can be one of the most time-consuming and complex factors of small business management. Yet, organizations that crack the code on streamlining employee compensation often discover innovative avenues for growth. With the right strategies in place, outsourcing and streamlining payroll processes can result in substantial time and resource savings.

article thumbnail

BDTX-4933 by Black Diamond Therapeutics for Central Nervous System (CNS) Tumor: Likelihood of Approval

Pharmaceutical Technology

BDTX-4933 is under clinical development by Black Diamond Therapeutics and currently in Phase I for Central Nervous System (CNS) Tumor.

40
article thumbnail

BDTX-4933 by Black Diamond Therapeutics for Metastatic Colorectal Cancer: Likelihood of Approval

Pharmaceutical Technology

BDTX-4933 is under clinical development by Black Diamond Therapeutics and currently in Phase I for Metastatic Colorectal Cancer.

40
article thumbnail

Y-101D by Wuhan YZY Biopharma for Gastric Cancer: Likelihood of Approval

Pharmaceutical Technology

Y-101D is under clinical development by Wuhan YZY Biopharma and currently in Phase II for Gastric Cancer.

40
article thumbnail

Y-101D by Wuhan YZY Biopharma for Metastatic Hepatocellular Carcinoma (HCC): Likelihood of Approval

Pharmaceutical Technology

Y-101D is under clinical development by Wuhan YZY Biopharma and currently in Phase II for Metastatic Hepatocellular Carcinoma (HCC).

40
article thumbnail

Enhance Healthcare Efficiency With Top Payroll & HCM Services

Running a healthcare facility requires precision and care, not just for patients but also for your staff. Our guide, "A Buyer’s Guide to Payroll & HCM Services," helps healthcare providers choose the best provider. Efficient payroll management ensures timely, accurate payments, critical for maintaining staff morale and trust. Compliance support helps navigate complex healthcare regulations and avoid costly fines.

article thumbnail

Y-101D by Wuhan YZY Biopharma for Metastatic Colorectal Cancer: Likelihood of Approval

Pharmaceutical Technology

Y-101D is under clinical development by Wuhan YZY Biopharma and currently in Phase II for Metastatic Colorectal Cancer.

40
article thumbnail

PRGN-3007 by Precigen for Hematological Tumor: Likelihood of Approval

Pharmaceutical Technology

PRGN-3007 is under clinical development by Precigen and currently in Phase I for Hematological Tumor.

40
article thumbnail

Dupilumab by Regeneron Pharmaceuticals for Atopic Keratoconjunctivitis: Likelihood of Approval

Pharmaceutical Technology

Dupilumab is under clinical development by Regeneron Pharmaceuticals and currently in Phase II for Atopic Keratoconjunctivitis.

40
article thumbnail

Capivasertib by AstraZeneca for Solid Tumor: Likelihood of Approval

Pharmaceutical Technology

Capivasertib is under clinical development by AstraZeneca and currently in Phase I for Solid Tumor.

40
article thumbnail

Position Your Pharmacy for Expansion

Speaker: Chris Antypas and Josh Halladay

Access to limited distribution drugs and payer contracts are key to pharmacy expansion. But how do you prepare your operations to take the next step? Meaningful data: Collect and share clinical data regarding outcomes, utilization, and more Reporting: Limited distribution models require efficient tracking and reporting systems Workflows: Align workflows with specific pharma and payer contractual requirements For in-depth, expert insights on pharmacy expansion, watch this webinar from Inovalon.

article thumbnail

Capivasertib by AstraZeneca for Triple-Negative Breast Cancer (TNBC): Likelihood of Approval

Pharmaceutical Technology

Capivasertib is under clinical development by AstraZeneca and currently in Phase III for Triple-Negative Breast Cancer (TNBC).

40
article thumbnail

Taladegib by Endeavor BioMedicines for Idiopathic Pulmonary Fibrosis: Likelihood of Approval

Pharmaceutical Technology

Taladegib is under clinical development by Endeavor BioMedicines and currently in Phase II for Idiopathic Pulmonary Fibrosis.

40
article thumbnail

Opaganib by RedHill Biopharma for Solid Tumor: Likelihood of Approval

Pharmaceutical Technology

Opaganib is under clinical development by RedHill Biopharma and currently in Phase I for Solid Tumor.

40
article thumbnail

Ribociclib succinate by Novartis for Prostate Cancer: Likelihood of Approval

Pharmaceutical Technology

Ribociclib succinate is under clinical development by Novartis and currently in Phase II for Prostate Cancer.

40
article thumbnail

5 Reasons to Upgrade Your Pharmacy Management Software

Are you still using workarounds to manage your daily operations? To achieve peak performance, it's time to explore other options for specialty and infusion pharmacy software. Streamline pharmacy operations and improve clinical performance with automated processing, real-time data exchange, and electronic decision support. Download this helpful infographic to: Drive efficiency and patient adherence from referral receipt to delivery and ongoing care – all with our Pharmacy Cloud.